The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Galkina O.V.

Nephrology Research Institute of the Pavlov University

Bogdanova E.O.

Nephrology Research Institute of the Pavlov University

Zubina I.M.

Nephrology Research Institute of the Pavlov University

Levykina E.N.

Nephrology Research Institute of the Pavlov University

Anpilova A.O.

Nephrology Research Institute of the Pavlov University

Sipovsky V.G.

Acad. I.P. Pavlov First Saint Petersburg State Medical University of the Ministry of Health of Russia

Karonova T.L.

Institute of Endocrinology of the Almazov National Medical Research Centre

Panina I.Yu.

Pavlov University

Smirnov A.V.

Federal Research and Clinical Center for Specialized Medical Care and Medical Technologies

25-hydroxyvitamine D and tubular lesions in chronic kidney disease

Authors:

Galkina O.V., Bogdanova E.O., Zubina I.M., Levykina E.N., Anpilova A.O., Sipovsky V.G., Karonova T.L., Panina I.Yu., Smirnov A.V.

More about the authors

Journal: Laboratory Service. 2021;10(2): 8‑17

Read: 1489 times


To cite this article:

Galkina OV, Bogdanova EO, Zubina IM, et al. 25-hydroxyvitamine D and tubular lesions in chronic kidney disease. Laboratory Service. 2021;10(2):8‑17. (In Russ.)
https://doi.org/10.17116/labs2021100218

Recommended articles:
Chro­nic kidney disease and microcirculation diso­rders. Russian Journal of Preventive Medi­cine. 2025;(8):123-130
Economics of hype­rparathyroidism. Part 2 — seco­ndary hype­rparathyroidism. Medi­cal Technologies. Asse­ssment and Choice. 2025;(3):74-82
A case report of successful pregnancy and childbirth in a patient with kidney transplant. Russian Bulletin of Obstetrician-Gynecologist. 2026;(2):53-57

References:

  1. Makibayashi K, Tatematsu M, Hirata M, Fukushima N, Kusano K, Ohashi S, Abe H, Kuze K, Fukatsu A, Kita T, Doi T. A vitamin D analog ameliorates glomerular injury on rat glomerulonephritis. American Journal of Pathology. 2001;158(5):1733-1741. https://doi.org/10.1016/S0002-9440(10)64129-6
  2. Kuhlmann A, Haas CS, Gross M-L, Reulbach U, Holzinger M, Schwarz U, Ritz E, Amann K. 1,25-Dihydroxyvitamin D3 decreases podocyte loss and podocyte hypertrophy in the subtotally nephrectomized rat. American Journal of Physiology Renal Physiology. 2004;286:526-533.  https://doi.org/10.1152/ajprenal.00316.2003
  3. Gembillo G, Cernaro V, Siligato R, Curreri F, Catalano A, Santoro D. Protective Role of Vitamin D in Renal Tubulopathies. Metabolites. 2020;10(3):115.  https://doi.org/10.3390/metabo10030115
  4. Tan X, Li Y, Liu Y. Therapeutic role and potential mechanisms of active vitamin D in renal interstitial fibrosis. The Journal of Steroid Biochemistry and Molecular Biology. 2007;103(3-5):491-496.  https://doi.org/10.1016/j.jsbmb.2006.11.011
  5. Deb KD, Sun T, Wong KE, Zhang Z, Ning G, Zhang Y, Kong J, Shi H, Chang A, Li Y C. Combined vitamin D analog and AT1 receptor antagonist synergistically block the development of kidney disease in a model of type 2 diabetes. Kidney International. 2010;77:1000-1009. https://doi.org/10.1038/ki.2010.22
  6. Sanchez-Nino M-D, Bozic M, Cordoba-Lanus E, Valcheva P, Gracia O, Ibarz M, Fernandez E, Navarro-Gonzalez JF, Ortiz A, Valdivielso JM. Beyond proteinuria: VDR activation reduces renal inflammation in experimental diabetic nephropathy. American Journal of Physiology Renal Physiology. 2012;302:647-657.  https://doi.org/10.1152/ajprenal.00090.2011
  7. Park JW, Bae EH, Kim IJ, Ma SK, Choi C, Lee J, Kim SW. Paricalcitol attenuates cyclosporine-induced kidney injury in rats. Kidney International. 2010;77(12):1076-1085. https://doi.org/10.1038/ki.2010.69
  8. Schwarz U, Amann K, Orth SR, Viciene AS, Wessels S, Ritz E. Effect of 1,25 (OH)2 vitamin D3 on glomerulosclerosis in subtotally nephrectomized rats. Kidney International. 1998;53:1696-1705. https://doi.org/10.1046/j.1523-1755.1998.00951.x
  9. He W, Kang YS, Dai C, Liu Y. Blockade of Wnt/beta-catenin signaling by paricalcitol ameliorates proteinuria and kidney injury. Journal of the American Society of Nephrology. 2011;22:90-103.  https://doi.org/10.1681/ASN.2009121236
  10. Park JW, Cho JW, Joo SY, Kim CS, Choi JS, Bae EH, Ma SK, Kim SH, JongUn Lee, Kim SW. Paricalcitol prevents cisplatin-induced renal injury by suppressing apoptosis and proliferation. European Journal of Pharmacology. 2012;683:301-309.  https://doi.org/10.1016/j.ejphar.2012.03.019
  11. Suh SH, Lee KE, Park JW, Kim IJ, Kim O, Kim CS, Choi JS, Bae EH, Ma SK, Lee JU, Kim SW. Antiapoptotic effect of paricalcitol in gentamicin-induced kidney injury. The Korean Journal of Physiology and Pharmacology. 2013;17(5):435-440.  https://doi.org/10.4196%2Fkjpp.2013.17.5.435
  12. Kim CS, Joo SY, Lee KE, Choi JS, Bae EH, Ma SK, Kim SH, Lee JU, Kim SW. Paricalcitol attenuates 4-hydroxy-2-hexenal-induced inflammation and epithelial-mesen-chymal transition in human renal proximal tubular epithelial cells. PLoS One. 2013;8(5):e63186. https://doi.org/10.1371%2Fjournal.pone.0063186
  13. Tan X, Li Y, Liu Y. Paricalcitol attenuates renal interstitial fibrosis in obstructive nephropathy. Journal of the American Society of Nephrology. 2007;17(12):3382-3393. https://doi.org/10.1681/ASN.2006050520
  14. Freundlich M, Quiroz Y, Zhang Z, Zhang Y, Btavo Y, Weisinger JR, Li YC, Rodriguez-Iturbe B. Suppression of renin-angiotensin gene expression in the kidney by paricalcitol. Kidney International. 2008;74(11):1394-1402. https://doi.org/10.1038/ki.2008.408
  15. Zhang Y, Deb DK, Kong J, Ning G, Wang Y, Li G, Chen Y, Zhang Z, Strugnell S, Sabbagh Y, Arbeeny C, Li YC. Long-term therapeutic effect of vitamin D analog doxercalciferol on diabetic nephropathy: strong synergism with AT1 receptor antagonist. American Journal of Physiology Renal Physiology. 2009;297(3):791-801.  https://doi.org/10.1152/ajprenal.00247.2009
  16. Li YC, Kong J, Wei M, Chen Z-F, Liu SQ, Cao L-P. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. The Journal of Clinical Investigation. 2002;110(2):229-238.  https://doi.org/10.1172%2FJCI15219
  17. Helvig CF, Cuerrier D, Hosfield CM, Ireland B, Kharebov AZ, Kim JW, Ramjit NJ, Ryder K, Tabash SP, Herzenberg AM, Epps TM, Petkovich M. Dysregulation of renal vitamin D metabolism in the uremic rat. Kidney International. 2010;78(5):463-472.  https://doi.org/10.1038/ki.2010.168
  18. Levey AS, Stevens LA, Schmid CH, Yaping (Lucy) Zhang Y(L), Castro AF, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J. A new equation to estimate glomerular filtration rate. Annals of Internal Medicine. 2009;150(9):604-612.  https://doi.org/10.7326/0003-4819-150-9-200905050-00006
  19. Hutchinson K, Healy M, Crowley V, Louw M, Rochev Y. Verification of Abbott 25-OH-vitamin D assay on the architect system. Practical Laboratory Medicine. 2017;7:27-35.  https://doi.org/10.1016/j.plabm.2017.01.001
  20. Karonova T, Andreeva A, Nikitina I, Belyaeva O, Mokhova E, Galkina O, Vasilyeva E, Grineva E. Prevalence of Vitamin D deficiency in the North-West region of Russia: A cross-sectional study. The Journal of steroid biochemistry and molecular biology. 2016;164:230-234.  https://doi.org/10.1016/j.jsbmb.2016.03.026
  21. Smirnov AV, Volkov MM. The role of vitamin D in progression of chronic kidney disease. Nephrology (Saint-Petersburg). 2008;12(4):20-27. (In Russ.). https://doi.org/10.24884/1561-6274-2008-12-4-20-27
  22. Tian J, Liu Y, Williams LA, de Zeeuw D. Potential role of active vitamin D in retarding the progression of chronic kidney disease. Nephrology Dialysis Transplantation. 2007;22(2):321-328.  https://doi.org/10.1093/ndt/gfl595
  23. Bogdanova EO, Beresneva ON, Galkina OV, Parastaeva MM, Zubina IM, Ivanova GT, Kayukov IG, Kucher AG, Smirnov AV. Vitamin D and fibroplastic processes in myocardium in spontaneously hypertensive rats with initial kidney dysfunction. »Arterial’naya Gipertenziya» («Arterial Hypertension»). 2020;26(1):107-118. (In Russ.). https://doi.org/10.18705/1607-419X-2020-26-1-107-118
  24. Bogdanova EO, Ivanova GT, Galkina OV, Zubina IM, Beresneva ON, Parastaeva MM, Kayukov IG, Dobronravov VA. Serum 25-hydroxyvitamin D is associated with renal fibrosis (experimental study). Nephrology (Saint-Petersburg). 2019;23(6):100-107. (In Russ.). https://doi.org/10.36485/1561-6274-2019-236-100-107
  25. Provvedini DM, Tsoukas CD, Deftos LJ, Manolagas SC. 1,25-dihydroxyvitamin D3 receptors in human leukocytes. Science. 1983;221:1181-1183. https://doi.org/10.1126/science.6310748
  26. Veldman CM, Cantorna MT, DeLuca HF. Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system. Archives of Biochemistry and Biophysics. 2000;374(2):334-338.  https://doi.org/10.1006/abbi.1999.1605
  27. Zeisberg M, Duffield JS. Resolved: EMT produces fibroblasts in the kidney. Journal of the American Society of Nephrology. 2010;21(8):1247-1253. https://doi.org/10.1681/ASN.2010060616
  28. Sato M, Muragaki Y, Saika S, Roberts AB, Ooshima A. Targeted disruption of TGF-beta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. The Journal of Clinical Investigation. 2003;112(10):1486-1494. https://doi.org/10.1172%2FJCI19270
  29. Rampanelli E, Rouschop K, Teske GJ, Claessen N, Leemans JC, Florquin S. CD44v3-v10 reduces the profibrotic effects of TGF-beta1 and attenuates tubular injury in the early stage of chronic obstructive nephropathy. American Journal of Physiology Renal Physiology. 2013;305:1445-1454. https://journals.physiology.org/doi/prev/20130911-aop/abs/10.1152/ajprenal.00340.2013
  30. Yoon HE, Yang CW. Established and newly proposed mechanisms of chronic cyclosporine nephropathy. The Korean Journal of Internal Medicine. 2009;24:81-92.  https://doi.org/10.3904%2Fkjim.2009.24.2.81
  31. Dabak DO, Kuloglu T, Ozercan MR. Effects of Vitamin D3 (Cholecalciferol) on Adriamycin-Induced Nephrotoxicity. Renal Failure. 2009;31:400-405.  https://doi.org/10.1080/08860220902883020
  32. Schwarz U, Amann K, Orth SR, Simonaviciene A, Wessels S, Ritz E. Effect of 1,25(OH)2 vitamin D3 on glomerulosclerosis in subtotally nephrectomized rats. Kidney International. 1998;53:1696-1705. https://doi.org/10.1046/j.1523-1755.1998.00951.x
  33. Panichi V, Migliori M, Taccola D, Filippi C, De Nisco L, Giovannini L, Palla R, Tetta C, Camussi G. Effects of 1,25(OH)2D in experimental mesangial proliferative nephritis in rats. Kidney International. 2001;60:87-95.  https://doi.org/10.1046/j.1523-1755.2001.00775.x
  34. Makibayshi K, Tatematsu M, Hirata M, Fukushima N, Kusano K, Ohashi S, Abe H, Kuze K, Fukatsu A, Kita T, Doi T. A vitamin D analog ameliorates glomerular injury on rat glomerulonephritis. The American Journal of Pathology. 2001;158:1733-1741. https://doi.org/10.1016%2FS0002-9440(10)64129-6
  35. Hirata M, Makibayashi K, Katsumata K, Kusano K, Watanabe T, Fukushima N, Doi T. 22-Oxacalcitriol prevents progressive glomerulosclerosis without adversely affecting calcium and phosphorus metabolism in subtotally nephrectomized rats. Nephrology Dialysis Transplantation. 2002;17:2132-2137. https://doi.org/10.1093/ndt/17.12.2132
  36. Zeisberg M, Duffield JS. Resolved: EMT produces fibroblasts in the kidney. Journal of the American Society of Nephrology. 2010;21:1247-1253. https://doi.org/10.1681/asn.2010060616
  37. Sato M, Muragaki Y, Saika S, Roberts AB, Ooshima A. Targeted disruption of TGF-beta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. The Journal of Clinical Investigation. 2003;112(10):1486-1494. https://doi.org/10.1172%2FJCI19270
  38. Mawer EB, Taylor CM, Backhouse J, Lumb JA, Stanbury SW. Failure of formation of 1,25-dihydroxycholecalciferol in chronic renal insufficiency. The Lancet. 1973;1:626-628.  https://doi.org/10.1016/S0140-6736(73)92197-1
  39. Satomura K, Seino Y, Yamaoka K, Tanaka Y, Ishida M, Yabuuchi H, Tanaka Y, DeLuca HF. Renal 25-hydroxyvitamin D3-1-hydroxylase in patients with renal disease. Kidney International. 1988;34:712-716.  https://doi.org/10.1038/ki.1988.237
  40. Helvig CF, Cuerrier D, Hosfield CM, Ireland B, Kharebov AZ, Kim JW, Ramjit NJ, Ryder K, Tabash SP, Herzenberg AM, Epps TM, Petkovich M. Dysregulation of renal vitamin D metabolism in the uremic rat. Kidney International. 2010;78(5):463-472.  https://doi.org/10.1038/ki.2010.168
  41. Akiyoshi-Shibata M, Sakaki T, Ohyama Y, Noshiro M, Okuda K, Yabusaki Y. Further oxidation ofhydroxycalcidiol by calcidiol 24-hydroxylase. A study with the mature enzyme expressed in Escherichia coli. European Journal of Biochemistry. 1994;224:335-343.  https://doi.org/10.1111/j.1432-1033.1994.00335.x
  42. Beckman MJ, Tadikonda P, Werner E, Prahl J, Yamada S, DeLuka HF. Human 25-hydroxyvitamin D3-24-hydroxylase, a multicatalytic enzyme. Biochemistry. 1996;35:8465-8472. https://doi.org/10.1021/bi960658i
  43. St-Arnaud R, Arabian A, Travers R, Barletta F, Raval-Pandya M, Chapin K, Depovere J, Mathieu C, Christakos S, Demay MB, Glorieux FH. Deficient mineralization of intramembranous bone in vitamin D-24-hydroxylase-ablated miceis due to elevated 1,25-dihydroxyvitamin D and not to the absence of 24,25-dihydroxyvitamin D. Endocrinology. 2000;141:2658-2666. https://doi.org/10.1210/endo.141.7.7579
  44. Masuda S, Byford V, Arabian A, Sakai Y, Demay MB, St-Arnaud R, Jones G. Altered pharmacokinetics of1alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse. Endocrinology. 2005;146:825-834.  https://www.researchgate.net/deref/http%3A%2F%2Fdx.doi.org%2F10.1210%2Fen.2004-1116
  45. Christensen EI, Birn H, Storm T, Weyer K, Nielsen R. Endocytic receptors in the renal proximal tubule. Physiology (Bethesda). 2012;27(4):223-236.  https://doi.org/10.1152/physiol.00022.2012

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.